Vestal Point Capital, LP Immatics N.V. Put Options Transaction History
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IMTX
# of Institutions
82Shares Held
91.5MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$75 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$47.9 Million1.77% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$46.7 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$43.9 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$37.2 Million0.39% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $390M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...